Curis Inc. Files 8-K: Material Agreement, Equity Sales Reported
Ticker: CRIS · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1108205
| Field | Detail |
|---|---|
| Company | Curis INC (CRIS) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
TL;DR
Curis Inc. filed an 8-K on July 1st, reporting a material agreement and equity sales. Details to follow.
AI Summary
Curis, Inc. filed an 8-K on July 2, 2025, reporting on events as of July 1, 2025. The filing indicates an entry into a material definitive agreement, unregistered sales of equity securities, and other events, including financial statements and exhibits. Specific details regarding the nature of the material agreement or the equity sales are not provided in this excerpt.
Why It Matters
This 8-K filing signals significant corporate actions by Curis, Inc., potentially impacting its financial structure and operational agreements.
Risk Assessment
Risk Level: medium — The filing indicates material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Curis, Inc. (company) — Registrant
- July 1, 2025 (date) — Date of earliest event reported
- July 2, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 000-30347 (identifier) — SEC file number
- 04-3505116 (identifier) — I.R.S. Employer Identification Number
- 128 Spring Street, Building C - Suite 500, Lexington, MA 02421 (address) — Principal Executive Offices
- 617-503-6500 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement entered into by Curis, Inc. as of July 1, 2025?
The provided excerpt does not specify the details of the material definitive agreement.
What type of equity securities were sold in the unregistered sale reported by Curis, Inc.?
The filing excerpt does not provide information on the specific type of equity securities sold.
What is the primary business of Curis, Inc.?
Curis, Inc. is in the business of Biological Products (No Diagnostic Substances), SIC code 2836.
When was Curis, Inc. incorporated?
Curis, Inc. was incorporated in Delaware.
What are the principal executive offices of Curis, Inc.?
The principal executive offices of Curis, Inc. are located at 128 Spring Street, Building C - Suite 500, Lexington, MA 02421.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding CURIS INC (CRIS).